Trial intelligence / Profile preview

Real-world pyrotinib for HER2-positive high-risk early breast cancer

ChiCTR2300070206Phase 4Not yet recruiting

Sponsor

Sun Yat-sen Memorial Hospital

Start

Jan 2023

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1